Marilyne Labrie Selected Research

Proteome

10/2023

The Breast Cancer Proteome and Precision Oncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marilyne Labrie Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 01/2013
11	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2013
9	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 09/2014
2	Neoplasm Metastasis (Metastasis) 05/2024 - 04/2014
2	Glioma (Gliomas) 01/2022 - 12/2021
2	Bites and Stings (Sting) 10/2021 - 01/2019
1	Lung Neoplasms (Lung Cancer) 05/2024
1	Residual Neoplasm 05/2022
1	Pathologic Complete Response 05/2022
1	Endometrial Neoplasms (Endometrial Cancer) 12/2021
1	Triple Negative Breast Neoplasms 10/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2019
1	Carcinoma (Carcinomatosis) 10/2017
1	Disease Progression 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 12/2013
1	Nervous System Diseases (Neurological Disorders) 12/2013
1	Alzheimer Disease (Alzheimer's Disease) 12/2013
1	Multiple Sclerosis 12/2013

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2013
6	Galectins (Galectin)IBA 10/2017 - 01/2013
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2022 - 01/2019
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 02/2018
2	Trastuzumab (Herceptin)FDA Link 10/2023 - 01/2021
2	Estrogen ReceptorsIBA 10/2023 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 10/2017
2	talazoparibIBA 05/2022 - 05/2019
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 12/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021 - 10/2019
2	ApolipoproteinsIBA 10/2019 - 02/2018
2	Apolipoproteins E (ApoE)IBA 02/2018 - 12/2013
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2013
1	ChromatinIBA 05/2024
1	Immune Checkpoint ProteinsIBA 05/2024
1	ProteomeIBA 10/2023
1	Gentian Violet (Violet, Crystal)FDA Link 01/2022
1	alpha-2'-deoxythioguanosineIBA 12/2021
1	NucleosidesIBA 12/2021
1	olaparibIBA 12/2021
1	capivasertibIBA 12/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	dactolisibIBA 01/2021
1	Therapeutic UsesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	CytokinesIBA 02/2018
1	Matrix Metalloproteinases (MMPs)IBA 02/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2018
1	AminopropionitrileIBA 02/2018
1	Inosine FDA Link 01/2018
1	NucleotidesIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	immune RNA (I-RNA)IBA 01/2018
1	AntigensIBA 10/2017
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 04/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	CarbohydratesIBA 01/2015
1	Etoposide (VP 16)FDA LinkGeneric 01/2015
1	Phenobarbital (Luminal)FDA Link 11/2014
1	matrigelIBA 09/2014
1	LigandsIBA 04/2014
1	GlycoconjugatesIBA 04/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2014
1	Apolipoproteins D (Apo D)IBA 12/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2013
1	EnzymesIBA 09/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013

Therapy/Procedure

13	Therapeutics 05/2024 - 04/2014
3	Immunotherapy 10/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2019 - 10/2017
1	Investigational Therapies (Experimental Therapy) 01/2022